Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
16530 | 649 | 35.1 | 72% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
6 | 4 | GASTROENTEROLOGY & HEPATOLOGY//ONCOLOGY//SURGERY | 1371034 |
375 | 3 | MELANOMA//DERMATOLOGY//DERMATOL | 32727 |
1048 | 2 | BASAL CELL CARCINOMA//DERMATOLOGY//SEBACEOUS CARCINOMA | 10099 |
16530 | 1 | ACTINIC KERATOSIS//INGENOL MEBUTATE//KERATOSIS ACTINIC | 649 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | ACTINIC KERATOSIS | authKW | 2194122 | 21% | 35% | 134 |
2 | INGENOL MEBUTATE | authKW | 1176204 | 5% | 83% | 30 |
3 | KERATOSIS ACTINIC | authKW | 523661 | 2% | 70% | 16 |
4 | ACTINIC KERATOSES | authKW | 332954 | 4% | 26% | 27 |
5 | LOCAL SKIN RESPONSES | authKW | 235243 | 1% | 100% | 5 |
6 | INGENOL MEBUTATE GEL | authKW | 196034 | 1% | 83% | 5 |
7 | SOLAR KERATOSIS | authKW | 193914 | 2% | 32% | 13 |
8 | DICLOFENAC 3 GEL | authKW | 150554 | 1% | 80% | 4 |
9 | FIELD DIRECTED TREATMENT | authKW | 141146 | 0% | 100% | 3 |
10 | FIELD THERAPY | authKW | 130686 | 1% | 56% | 5 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Dermatology | 56322 | 70% | 0% | 456 |
2 | Oncology | 131 | 9% | 0% | 61 |
3 | Surgery | 75 | 8% | 0% | 52 |
4 | Primary Health Care | 30 | 1% | 0% | 5 |
5 | Pharmacology & Pharmacy | 18 | 6% | 0% | 38 |
6 | Medicine, General & Internal | 17 | 4% | 0% | 27 |
7 | Pathology | 17 | 2% | 0% | 14 |
8 | Health Policy & Services | 16 | 1% | 0% | 7 |
9 | Ophthalmology | 12 | 2% | 0% | 12 |
10 | Health Care Sciences & Services | 9 | 1% | 0% | 8 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | EXCELLENCE SCI AFFAIRS | 94097 | 0% | 100% | 2 |
2 | FISIOL ANIM FISIOL VEGETAL ECOL | 94097 | 0% | 100% | 2 |
3 | IFO IST DERMATOL | 94097 | 0% | 100% | 2 |
4 | SKIN CANC CHARITE | 76431 | 2% | 13% | 13 |
5 | CLIN COSMET | 62730 | 0% | 67% | 2 |
6 | ADULT HEATH NURSE PRACTITIONER PROGRAM | 47049 | 0% | 100% | 1 |
7 | ANESTHESIA INTENS THER Y DERMATOL SCI | 47049 | 0% | 100% | 1 |
8 | AO SAN MARTINO | 47049 | 0% | 100% | 1 |
9 | AREA HLTH EDUC SW | 47049 | 0% | 100% | 1 |
10 | AREA IMUNOL | 47049 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | JOURNAL OF DRUGS IN DERMATOLOGY | 23665 | 4% | 2% | 29 |
2 | GIORNALE ITALIANO DI DERMATOLOGIA E VENEREOLOGIA | 13924 | 2% | 2% | 13 |
3 | BRITISH JOURNAL OF DERMATOLOGY | 13856 | 9% | 1% | 57 |
4 | JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 9238 | 8% | 0% | 49 |
5 | JOURNAL OF DERMATOLOGICAL TREATMENT | 8964 | 2% | 1% | 16 |
6 | DERMATOLOGIC SURGERY | 8865 | 4% | 1% | 28 |
7 | JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY | 8793 | 4% | 1% | 26 |
8 | CUTIS | 8158 | 4% | 1% | 27 |
9 | JOURNAL OF CUTANEOUS MEDICINE AND SURGERY | 5753 | 2% | 1% | 10 |
10 | EUROPEAN JOURNAL OF DERMATOLOGY | 3974 | 2% | 1% | 15 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | ACTINIC KERATOSIS | 2194122 | 21% | 35% | 134 | Search ACTINIC+KERATOSIS | Search ACTINIC+KERATOSIS |
2 | INGENOL MEBUTATE | 1176204 | 5% | 83% | 30 | Search INGENOL+MEBUTATE | Search INGENOL+MEBUTATE |
3 | KERATOSIS ACTINIC | 523661 | 2% | 70% | 16 | Search KERATOSIS+ACTINIC | Search KERATOSIS+ACTINIC |
4 | ACTINIC KERATOSES | 332954 | 4% | 26% | 27 | Search ACTINIC+KERATOSES | Search ACTINIC+KERATOSES |
5 | LOCAL SKIN RESPONSES | 235243 | 1% | 100% | 5 | Search LOCAL+SKIN+RESPONSES | Search LOCAL+SKIN+RESPONSES |
6 | INGENOL MEBUTATE GEL | 196034 | 1% | 83% | 5 | Search INGENOL+MEBUTATE+GEL | Search INGENOL+MEBUTATE+GEL |
7 | SOLAR KERATOSIS | 193914 | 2% | 32% | 13 | Search SOLAR+KERATOSIS | Search SOLAR+KERATOSIS |
8 | DICLOFENAC 3 GEL | 150554 | 1% | 80% | 4 | Search DICLOFENAC+3+GEL | Search DICLOFENAC+3+GEL |
9 | FIELD DIRECTED TREATMENT | 141146 | 0% | 100% | 3 | Search FIELD+DIRECTED+TREATMENT | Search FIELD+DIRECTED+TREATMENT |
10 | FIELD THERAPY | 130686 | 1% | 56% | 5 | Search FIELD+THERAPY | Search FIELD+THERAPY |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | NASHAN, D , MEISS, F , MULLER, M , (2013) THERAPEUTIC STRATEGIES FOR ACTINIC KERATOSES - A SYSTEMATIC REVIEW.EUROPEAN JOURNAL OF DERMATOLOGY. VOL. 23. ISSUE 1. P. 14 -32 | 92 | 54% | 17 |
2 | DE BERKER, D , MCGREGOR, JM , MUSTAPA, MFM , EXTON, LS , HUGHES, BR , (2017) BRITISH ASSOCIATION OF DERMATOLOGISTS' GUIDELINES FOR THE CARE OF PATIENTS WITH ACTINIC KERATOSIS 2017.BRITISH JOURNAL OF DERMATOLOGY. VOL. 176. ISSUE 1. P. 20 -43 | 79 | 55% | 0 |
3 | PESERICO, A , NERI, L , PINTON, PC , CATRICALA, C , PELLACANI, G , PERIS, K , PIMPINELLI, N , (2013) KEY OPINION LEADER (KOL) CONSENSUS FOR ACTINIC KERATOSIS MANAGEMENT IN ITALY: THE AKTUAL WORKSHOP.GIORNALE ITALIANO DI DERMATOLOGIA E VENEREOLOGIA. VOL. 148. ISSUE 5. P. 515-524 | 55 | 85% | 1 |
4 | GUPTA, AK , PAQUET, M , VILLANUEVA, E , BRINTNELL, W , (2012) INTERVENTIONS FOR ACTINIC KERATOSES.COCHRANE DATABASE OF SYSTEMATIC REVIEWS. VOL. . ISSUE 12. P. - | 76 | 54% | 8 |
5 | GARBE, C , BASSET-SEGUIN, N , POULIN, Y , LARSSON, T , OSTERDAL, ML , VENKATA, R , LEAR, JT , (2016) EFFICACY AND SAFETY OF FOLLOW-UP FIELD TREATMENT OF ACTINIC KERATOSIS WITH INGENOL MEBUTATE 0.015% GEL: A RANDOMIZED, CONTROLLED 12-MONTH STUDY.BRITISH JOURNAL OF DERMATOLOGY. VOL. 174. ISSUE 3. P. 505 -513 | 25 | 96% | 4 |
6 | HOFBAUER, G , ANLIKER, M , BOEHNCKE, WH , BRAND, C , BRAUN, R , GAIDE, O , HAFNER, J , HUNGER, R , ITIN, P , KAEUPER, G , ET AL (2014) SWISS CLINICAL PRACTICE GUIDELINES ON FIELD CANCERIZATION OF THE SKIN.SWISS MEDICAL WEEKLY. VOL. 144. ISSUE . P. - | 56 | 54% | 5 |
7 | SCHMITT, AR , BORDEAUX, JS , (2013) SOLAR KERATOSES: PHOTODYNAMIC THERAPY, CRYOTHERAPY, 5-FLUOROURACIL, IMIQUIMOD, DICLOFENAC, OR WHAT? FACTS AND CONTROVERSIES.CLINICS IN DERMATOLOGY. VOL. 31. ISSUE 6. P. 712-717 | 38 | 83% | 4 |
8 | GUPTA, AK , PAQUET, M , (2013) INGENOL MEBUTATE: A PROMISING TREATMENT FOR ACTINIC KERATOSES AND NONMELANOMA SKIN CANCERS.JOURNAL OF CUTANEOUS MEDICINE AND SURGERY. VOL. 17. ISSUE 3. P. 173-179 | 38 | 79% | 8 |
9 | FELDMAN, SR , FLEISCHER, AB , (2011) PROGRESSION OF ACTINIC KERATOSIS TO SQUAMOUS CELL CARCINOMA REVISITED: CLINICAL AND TREATMENT IMPLICATIONS.CUTIS. VOL. 87. ISSUE 4. P. 201-207 | 35 | 80% | 39 |
10 | KO, CJ , (2010) ACTINIC KERATOSIS: FACTS AND CONTROVERSIES.CLINICS IN DERMATOLOGY. VOL. 28. ISSUE 3. P. 249 -253 | 40 | 75% | 14 |
Classes with closest relation at Level 1 |